Depression in Parkinson's disease: Diagnosis and management

British Journal of Hospital Medicine

Volumn 73, Issue 6, 2012, Pages 331-334

  Latoo, Javed ^a   Mistry, Minal ^b   Dunne, Francis J ^c  

^a 5 Boroughs Partnership NHS Trust   (United Kingdom)

^b SOUTHERN HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862696526     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2012.73.6.331     Document Type: Review

References (42)

1. Antonini A, Tesei S, Zecchinelli A et al (2006) Randomised study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression - effect on quality of life. Mov Disord 21:1119-22 (Pubitemid 44336595)
2. Barone P, Poewe W, Albrecht S et al (2010) Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:573-80
3. da Silva TM, Munhoz R P, Alvarez CC, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC (2008) Depression in Parkinson's disease: a double-blind, randomised, placebo-controlled pilot study of omega-3 fatty-acid supplementation. J Affect Disord 111:351-9
4. Defazio G, Berardelli A, Fabbrini G et al (2008) Pain as a non-motor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 65:1191-4
5. Djaldetti R, Yust-Katz S, Kolianov V, Melamed E, Dabby R (2007) The effect of duloxetine on primary pain symptoms in Parkinson's disease. Clin Neuropharmacol 30:201-5 (Pubitemid 47356716)
6. Dobkin RD, Allen LA, Menza M (2006) A cognitive-behavioural treatment package for depression in Parkinson's disease. Psychosomatics 47:259-63 (Pubitemid 46940486)
7. Dubois B, Pillon B (1997) Cognitive deficits in Parkinson's disease. J Neurol 244:2-8 (Pubitemid 26413891)
8. Dunne FJ (1993) Subcortical dementia. BMJ 307:1-2 (Pubitemid 23181078)
9. Ehrt U, Larsen J P, Aarsland D (2009) Pain and its relationship to depression in Parkinson disease. Am J Geriatr Psychiatry 17:269-75
10. Farabaugh AH, Locascio JJ, Yap L et al (2009) Pattern of depressive symptoms in Parkinson's disease. Psychosomatics 50:448-54
11. Fernandez HH, Merello M (2010) Pramipexole for depression and motor symptoms in Parkinson's disease: can we kill two birds with one stone? Lancet Neurol 9:556-7
12. Fitzgerald PB, Daskalakis ZJ (2008) The use of repetitive transcranial magnetic stimulation and vagal nerve stimulation in the treatment of depression. Curr Opin Psychiatry 21:25-9 (Pubitemid 351339804)
13. Frisina PG, Borod JC, Foldi NS, Tenenbaum HR (2008) Depression in Parkinson's disease: health risks, etiology, and treatment options. Neuropsychiatr Dis Treat 4:81-91 (Pubitemid 351460982)
14. Frisina PG, Haroutunian V, Libow LS (2009) The neuropathological basis for depression in Parkinson's disease. Parkinsonism Relat Disord 15:144-8
15. Jankovic J (2008) Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79(4):368-76 (Pubitemid 351441488)
16. Kostic VS, Pekmezovic T, Tomic A et al (2010) Suicide and suicidal ideation in Parkinson's disease. J Neurol Sci 289:40-3
17. Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, Gironell A, García-Sánchez C, Martínez-Corral M (2008) Motor changes during sertraline treatment in depressed patients with Parkinson's disease. Eur J Neurol 15:953-9
18. Kummer A, Teixeira AL (2009) Neuropsychiatry of Parkinson's disease. Arq Neuropsiquitr 67:930-9
19. Kummer A, Cardoso F, Teixeira AL (2009) Suicide ideation in Parkinson's disease. CNS Spectr 14:431-6
20. Lees AJ, Hardy J, Revesz T (2009) Parkinsons Disease. Lancet 373(9680):2055-66
21. Lemke MR (2008) Depressive symptoms in Parkinson's disease. Eur J Neurol 15(suppl 1):21-5 (Pubitemid 351421306)
22. Lieberman A (2006) Depression in Parkinson's disease - a review. Acta Neurol Scand 113:1-8
23. Mainio A, Karvonen K, Hakko H, Särkioja T, Räsänen P (2009) Parkinson's disease and suicide: a profile of suicide victims with Parkinson's disease in a population-based study during the years 1988-2002 in Northern Ireland. Int J Geriatr Psychiatry 24:916-20
24. Marino S, Sessa E, Di Lorenzo G, Digangi G, Alagna A, Bramanti P, Di Bella P (2008) Sertraline in the treatment of depressive disorders in patients with Parkinson's disease. Neurol Sci 29:391-5
25. McDonald WM, Richard IH, Mahlon RD (2003) Prevalence, aetiology and treatment of depression in Parkinson's disease. Biol Psychiat 54:363-75 (Pubitemid 37267863)
26. McDonald WM, Holtzheimer III PE, Byrd EH (2006) The diagnosis and treatment of depression in Parkinson's disease. Curr Treat Options Neurol 8:245-55
27. Menza M, Dobkin RD, Marin H et al (2009) A controlled trial of antidepressants in patients with Parkinson's disease and depression. Neurology 72:886-92
28. Mitchel AJ (2004) Neuropsychiatry and Behavioural Neurology Explained. Saunders, London: 148-9
29. Mondolo F, Jahanshahi M, Granà A, Biasutti E, Cacciatori E, Di Benedetto P (2006) The validity of the hospital and depression scale and the geriatric depression scale in Parkinson's disease. Behav Neurol 17:109-15 (Pubitemid 44078634)
30. Munhoz R P, Teive HA, Troiano AR, Hauck PR, Herdoiza Leiva MH, Graff H, Werneck LC (2004) Parkinson's disease and thyroid dysfunction. Parkinsonism Relat Disord 10:381-3 (Pubitemid 38942795)
31. Nazem S, Siderowf AD, Duda JE, Brown GK, Ten Have T, Stern MB, Weintraub D (2008) Suicidal and death ideation in Parkinson's disease. Mov Disord 23:1573-9
32. Pålhagen SE, Carlsson M, Curman E, Wålinder J, Granérus AK (2008) Depressive illness in Parkinson's disease - indication of a more advanced and widespread neurodegenerative process? Acta Neurol Scand 117:295-304
33. Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC, Foroud T; Parkinson's Study Group-PROGENI Investigators (2008) Clinical correlates of depressive symptoms in familial Parkinson's disease. Mov Disord 23:2216-23
34. Paulus W, Jellinger K (1991) The neuropathologial basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 50:743-55
35. Pintor L, Baillès E, Valldeoriola F, Tolosa E, Martí MJ, de Pablo J (2006) Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode. Gen Hosp Psychiatry 28:59-64 (Pubitemid 41827570)
36. Richard IH, McDermott M P, Kurlan R et al (2012) A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 78:1229-36
37. Schneider CB, Piulhatsch M, Rifati M et al (2010) Utility of the WHO-five well-being index as a screening tool for depression in Parkinson's disease. Mov Disord 25:777-83
38. Schrag A, Barone P, Brown R et al (2007) Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 22:1077-92 (Pubitemid 47067217)
39. Serrano-Duenas M (2002) A comparison between low-dose of amitriptyline and low-dose of fluoxetine used in control of depression in patients suffering from Parkinson's disease. Rev Neurol 35:1010-14 (Pubitemid 36139281)
40. Soldani P, Fornai F (1999) The functional anatomy of noradrenergic neurones in Parkinson's disease. Functional Neurol 14:97-109 (Pubitemid 29333835)
41. Soulas T, Gurruchaga J-M, Palfi S, Cesaro P, Nguyen J P, Fénelon G (2008) Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease. J Neurol Neurosurg Psychiatry 79:952-4
42. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, Middelkoop HA, van Hilten JJ (2007) Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry 117:1182-7 (Pubitemid 350057278)